Abtmed 250mg Tablet
Rx RequiredSalt Composition: Abiraterone Acetate
Expiry Date: 01/2028
Buy at $146.35
Inclusive of all taxes
120 Tablet in Bottle
About The Product
Prostate Cancer
Abtmed 250mg Tablet is used to treat prostate cancer in men that has spread to nearby organs. It is only prescribed for early-stage cancer. This drug reduces the secretion of male sex hormones, androgen, and testosterone & prevents the multiplication of the cancer cells in the body. Abtmed is not recommended for women and children.
Description
Abtmed 250mg Tablet is a hormonal therapy drug consisting of its active constituent abiraterone acetate. The doctor prescribes this tablet to treat early-stage prostate cancer in men.
Abtmed 250mg Tablet is usually given with a steroid to lower the side effects of other anticancer medicines. This medicine reduces the secretion of male sex hormones by inhibiting the enzyme's action.
Abtmed 250mg Tablet also relieves the associated symptoms such as difficulty in passing the urine. This tablet can also be a combination drug in other cancer therapies.
Before taking the Abtmed tablet, share with your doctor if you have high blood pressure, heart disease, or kidney, or liver problems. Taking Abtmed 250mg Tablet can cause a drop in blood cell count, blood sugar, and kidney parameters, so your physician must monitor it regularly.
Inform your doctor if you are taking any prescribed and non-prescribed medications. These medicines can interact with Abtmed 250mg Tablet and may result in some undesirable effects.
It is advised to use reliable methods of birth control and contraceptive pills to avoid pregnancy while under treatment. Abtmed 250mg Tablet should not be given to pregnant and breastfeeding women, as it may pass through the mother and harm the baby.
This medicine should not be taken with Ra-223, which is another anticancer medicine to treat prostate cancer.
Side Effects
Like other anticancer medicines, Abtmed 250mg Tablet also has some common to severe side effects. These are undesired symptoms observed in the body after taking this tablet. Usually, they disappear with time as the body adjusts to the medicine. These adverse effects don't need special medical attention, but if you observe them continually, talk to your medical expert. Some of them are listed below:
Common side effects:
Vomiting
Diarrhea
Swelling
Joint pain
Fatigue
Cough
High BP
Constipation
Chest pain
Irregular & fast heart rate
Rashes
Severe side effects:
Urinary Tract Infection
Decreased potassium level in blood
Low blood count
Blood in urine
How To Use
- Abtmed 250mg Tablet is a prescription-based anticancer drug that should be administered orally.
- It is advised to take this tablet after consulting your healthcare expert.
How It Works
Abtmed 250mg Tablet is an anticancer medicine used in hormonal therapy of prostate cancer. This medicine inhibits the action of the enzyme CYP17 which is responsible for the production of androgen and testosterone in males.
It slows down the growth and multiplication of the cancer cells. Eventually, it restricts the cancer from spreading to other parts of the body and leads to death.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Abtmed 250mg Tablet.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
Abtmed 250mg Tablet is usually taken with another medicine, prednisolone to reduce unwanted side effects.
Your healthcare expert must monitor your blood sugar & pressure, potassium level, and liver function tests at regular intervals. Taking the Abtmed 250mg Tablet can cause fluctuations in their levels.
Inform your doctor if you have diabetes, or any heart, liver, and kidney problems before taking Abtmed 250mg Tablet.
Use reliable methods of birth control and contraceptive pills to avoid pregnancy while under treatment with Abtmed 250mg Tablet.
Abtmed 250mg Tablet contains lactose and sodium, share with your physician if you have lactose intolerance.
FAQs
Abtmed 250mg tablet is used as a hormonal therapy drug.
The doctor prescribes this tablet for treating early-stage prostate cancer in men that has spread to other nearby parts of the body.
Reference
Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. (2023).
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Eur Urol. 65:467-79.
Hellerstedt BA, Pienta KJ. (2024).
The current state of hormonal therapy for prostate cancer. CA Cancer J Clin.
52:154-79. Lu, X., Dai, T., Chen, X. et al.
(2025). A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer.
BMC Med 23, 271 (2025). Mandal S, Tarigopula V, Kumaraswamy S, Das MK, Tripathy S, Barik K, Nayak P.
(2024). Do Indian men have similar oncological outcomes with abiraterone plus androgen deprivation therapy in the setting of metastatic hormone-sensitive prostate cancer?
A prospective observational study. Indian J Urol.
40(3):174-178. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, et al.
(2024). Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth.
Cancer Res. 68:4447-54.
Shameem R, Hamid MS, Xu KY, Wu S. (2024).
Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer. World J Clin Oncol.
6(4):64-72. Ye D, Huang Y, Zhou F, Xie K, Matveev V, Li C, Alexeev B, Tian Y, Qiu M, Li H, Zhou T, De Porre P, Yu M, Naini V, Liang H, Wu Z, Sun Y.
(2024). A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand, and Russia.
Asian J Urol. 4(2):75-85.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.png&w=48&q=75 "Cart"){kind=small}
9655.png&w=48&q=75 "Home"){kind=small}
